[1] |
LI Miao, YU Qinwei, JIANG Zhenzhou, ZHANG Luyong, .
Regulatory mechanism of LDLR and research progress of its related diseases and drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 946-954.
|
[2] |
LIU Yanzhi, WANG Yan, LIU Kaili, ZHOU Wenhua, ZHU Ping, WANG Yingli, DU Shouying.
Inhibition and mechanism of Xihuang pill on mice bearing hepatoma H22 tumor
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(7): 754-761.
|
[3] |
DING Hao, GAO Zhenhua, ZHENG Yun.
Research progress of microRNA in diagnosis and treatment of prostate cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 696-708.
|
[4] |
ZHOU Guangchen, LIU Yixi, ZHENG Yun.
Colorectal cancer and microRNA: research progress
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(5): 575-587.
|
[5] |
DENG Ying, BAI Shutong.
Research advance of chrysoeriol on its pharmacological action and underlying mechnism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(10): 1155-1162.
|
[6] |
PENG Jing, SONG Jing, LUAN Jiajie.
Mesenchymal Stem Cells: a new discovery in the treatment of novel coronavirus pneumonia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1073-1079.
|
[7] |
HAO Haiping.
Metabolic regulation and drug target discovery researches in China: Progress and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 955-963.
|
[8] |
YE Peng, TAN Xing, LENG Yueqi, WANG Yangkai, WANG Weizhong.
Current opinions and developments of non-pharmacological treatments of hypertension based on sympathetic nervous system
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(12): 1335-1343.
|
[9] |
XU Lina, LI Yue, PENG Jinyong.
microRNA and drug-induced liver injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(7): 803-809.
|
[10] |
JIANG Bingbing.
Research progress on microRNAs in Huntington's disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 677-685.
|
[11] |
LIU Yadong, LU Xiaowei, LIU Zhigang.
Effects of EPO on serum calcitonin gene-related peptide in patients with acute spinal cord injury
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(8): 933-937.
|
[12] |
LIU Li, PENG Jinfu, GUO Chengxian, YANG Xiding, LI Haigang, YANG Guoping.
Regulative effects of miR-150 on CYP3A4
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 749-754.
|
[13] |
XU Wei, QU Weimin, HONG Zongyuan.
Advances in research on the mechanism of general anesthesia by specific manipulation of neuron activities
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(7): 825-829.
|
[14] |
CHEN Dan, GUO Yujin, YANG Mengqi, CA Hualin, JIANG Pei.
Advances in studies of neurotoxicity of angiotensin(1-7)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(12): 1425-1430.
|
[15] |
XU Shujuan, LV Dalun, CHEN Lei, DING Wei, WANG Heli, ZHANG Wei, WANG Shuai.
Effect of rHuEPO on the change of Ang-1 during acute skin wound healing in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 424-427.
|